Minerva Neurosciences Long Term Deferred Assets (Quarterly) Insights

Minerva Neurosciences, Inc. (NERV)

4.19 -0.18 (-4.12%) USD | NASDAQ | Jan 21, 16:00

4.20 +0.01 (+0.24%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for NERV.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

iBio, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--
Oragenics, Inc.	--